Involvement of Sp1 and Sp3 in differential regulation of human NHE3 promoter activity by sodium butyrate and IFN-γ/TNF-α

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 293, Issue 1, 2007, Pages

  Amin, Md Ruhul ^a   Dudeja, Pradeep K ^a,b   Ramaswamy, Krishnamurthy ^a,b   Malakooti, Jaleh ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

C2BBe1 cell line; Sodium hydrogen exchanger

Indexed keywords

BUTYRIC ACID; CYTOKINE; GAMMA INTERFERON; NUCLEAR PROTEIN; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; SMALL INTERFERING RNA; SODIUM PROTON EXCHANGE PROTEIN 3; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; WESTERN BLOTTING;

BUTYRATES; CACO-2 CELLS; HUMANS; INTERFERON TYPE II; PHOSPHOPROTEIN PHOSPHATASE; PROMOTER REGIONS (GENETICS); SODIUM-HYDROGEN ANTIPORTER; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547107899     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00128.2007     Document Type: Article

References (47)

1. Amin MR, Malakooti J, Sandoval R, Dudeja PK, Ramaswamy K. IFN-γ and TNF-α regulate human NHE3 gene expression by modulating the Sp family transcription factors in human intestinal epithelial cell line C2BBe1. Am J Physiol Cell Physiol 291: C887-C896, 2006.
2. Andoh A, Fujiyama Y, Hata K, Araki Y, Takaya H, Shimada M, Bamba T. Counter-regulatory effect of sodium butyrate on tumour necrosis factor-7alpha; (TNF-α)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells. Clin Exp Immunol 118: 23-29, 1999.
3. Armstrong SA, Barry DA, Leggett RW, Mueller CR. Casein kinase II-mediated phosphorylation of the C terminus of Sp1 decreases its DNA binding activity. J Biol Chem 272: 13489-13495, 1997.
4. + exchanger isoform 5 (NHE5) from human brain. J Biol Chem 274: 4377-4382, 1999.
5. Bialojan C, Takai A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem J 256: 283-290, 1988.
6. Briggs MR, Kadonaga JT, Bell SP, Tjian R. Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science 234: 47-52, 1986.
7. Buquet-Fagot C, Lallemand F, Charollais RH, Mester J. Sodium butyrate inhibits the phosphorylation of the retinoblastoma gene product in mouse fibroblasts by a transcription-dependent mechanism. J Cell Physiol 166: 631-636, 1996.
8. Camarero N, Nadal A, Barrero MJ, Haro D, Marrero PF. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site. Nucleic Acids Res 31: 1693-1703, 2003.
9. Chen X, Azizkhan JC, Lee DC. The binding of transcription factor Sp1 to multiple sites is required for maximal expression from the rat transforming growth factor alpha promoter. Oncogene 7: 1805-1815, 1992.
10. Clausen MR, Bonnen H, Tvede M, Mortensen PB. Colonic fermentation to short-chain fatty acids is decreased in antibiotic-associated diarrhea. Gastroenterology 101: 1497-1504, 1991.
11. Cominelli F. Cytokine-based therapies for Crohn's disease - new paradigms. N Engl J Med 351: 2045-2048, 2004.
12. Cuisset L, Tichonicky L, Jaffray P, Delpech M. The effects of sodium butyrate on transcription are mediated through activation of a protein phosphatase. J Biol Chem 272: 24148-24153, 1997.
13. Daniel S, Zhang S, DePaoli-Roach AA, Kim KH. Dephosphorylation of Sp1 by protein phosphatase 1 is involved in the glucose-mediated activation of the acetyl-CoA carboxylase gene. J Biol Chem 271: 14692-14697, 1996.
14. el-Baradi T, Pieler T. Zinc finger proteins: what we know and what we would like to know. Mech Dev 35: 155-169, 1991.
15. Elson CO, Cong Y, Lorenz R, Weaver CT. New developments in experimental models of inflammatory bowel disease. Curr Opin Gastroenterol 20: 360-367, 2004.
16. Fish SM, Proujansky R, Reenstra WW. Synergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function. Gut 45: 191-198, 1999.
17. Gilbert KM, Weigle WO. Th1 cell anergy and blockade in G1a phase of the cell cycle. J Immunol 151: 1245-1254, 1993.
18. Hague A, Singh B, Paraskeva C. Butyrate acts as a survival factor for colonic epithelial cells: further fuel for the in vivo versus in vitro debate. Gastroenterology 112: 1036-1040, 1997.
19. Heerdt BG, Houston MA, Augenlicht LH. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res 54: 3288-3293, 1994.
20. + exchanger isoform 3 in human colon adenocarcinoma cell line Caco-2. Protein kinase C-mediated inhibition of the exchanger. J Biol Chem 273: 8790-8798, 1998.
21. Kiela PR, Hines ER, Collins JF, Ghishan FK. Regulation of the rat NHE3 gene promoter by sodium butyrate. Am J Physiol Gastrointest Liver Physiol 281: G947-G956, 2001.
22. Kiela PR, LeSueur J, Collins JF, Ghishan FK. Transcriptional regulation of the rat NHE3 gene. Functional interactions between GATA-5 and Sp family transcription factors. J Biol Chem 278: 5659-5668, 2003.
23. Klampfer L, Huang J, Sasazuki T, Shirasawa S, Augenlicht L. Inhibition of interferon gamma signaling by the short chain fatty acid butyrate. Mol Cancer Res 1: 855-862, 2003.
24. Kumar AP, Mar PK, Zhao B, Montgomery RL, Kang DC, Butler AP. Regulation of rat ornithine decarboxylase promoter activity by binding of transcription factor Sp1. J Biol Chem 270: 4341-4348, 1995.
25. Lacroix I, Lipcey C, Imbert J, Kahn-Perles B. Sp1 transcriptional activity is up-regulated by phosphatase 2A in dividing T lymphocytes. J Biol Chem 277: 9598-9605, 2002.
26. Leggett RW, Armstrong SA, Barry D, Mueller CR. Sp1 is phosphorylated and its DNA binding activity down-regulated upon terminal differentiation of the liver. J Biol Chem 270: 25879-25884, 1995.
27. Lu J, Lee W, Jiang C, Keller EB. Start site selection by Sp1 in the TATA-less human Ha-ras promoter. J Biol Chem 269: 5391-5402, 1994.
28. + exchanger NHE2 gene: genomic organization and promoter characterization. Am J Physiol Gastrointest Liver Physiol 280: G763-G773, 2001.
29. + exchanger NHE3 promoter. Am J Physiol Gastrointest Liver Physiol 282: G491-G500, 2002.
30. Malakooti J, Sandoval R, Amin MR, Clark J, Dudeja PK, Ramaswamy K. Transcriptional stimulation of the human NHE3 promoter activity by PMA: PKC independence and involvement of the transcription factor EGR-1. Biochem J 396: 327-336, 2006.
31. Musch MW, Bookstein C, Xie Y, Sellin JH, Chang EB. SCFA increase intestinal Na absorption by induction of NHE3 in rat colon and human intestinal C2/bbe cells. Am J Physiol Gastrointest Liver Physiol 280: G687-G693, 2001.
32. Nakano K, Mizuno T, Sowa Y, Orita T, Yoshino T, Okuyama Y, Fujita T, Ohtani-Fujita N, Matsukawa Y, Tokino T, Yamagishi H, Oka T, Nomura H, Sakai T. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J Biol Chem 272: 22199-22206, 1997.
33. Peterson MD, Mooseker MS. Characterization of the enterocyte-like brush border cytoskeleton of the C2BBe clones of the human intestinal cell line, Caco-2. J Cell Sci 102: 581-600, 1992.
34. Reisinger K, Kaufmann R, Gille J. Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription. J Cell Sci 116: 225-238, 2003.
35. + exchangers NHE2 and NHE3 in rat intestine and human Caco-2/bbe cells. Am J Physiol Cell Physiol 280: C1224-C1232, 2001.
36. Rohlff C, Ahmad S, Borellini F, Lei J, Glazer RI. Modulation of transcription factor Sp1 by cAMP-dependent protein kinase. J Biol Chem 272: 21137-21141, 1997.
37. Scheppach W, Weiler F. The butyrate story: old wine in new bottles? Curr Opin Clin Nutr Metab Care 7: 563-567, 2004.
38. Schonthal AH. Role of PP2A in intracellular signal transduction pathways. Front Biosci 3: D1262-D1273, 1998.
39. Schwartz B, Avivi-Green C, Polak-Charcon S. Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells. Mol Cell Biochem 188: 21-30, 1998.
40. Segain JP, Raingeard de la Bletiere D, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier L, Bonnet C, Blottiere HM, Galmiche JP. Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease. Gut 47: 397-403, 2000.
41. Tamaki T, Ohnishi K, Hartl C, LeRoy EC, Trojanowska M. Characterization of a GC-rich region containing Sp1 binding site(s) as a constitutive responsive element of the alpha 2(I) collagen gene in human fibroblasts. J Biol Chem 270: 4299-4304, 1995.
42. Tripuraneni J, Koutsouris A, Pestic L, De Lanerolle P, Hecht G. The toxin of diarrheic shellfish poisoning, okadaic acid, increases intestinal epithelial paracellular permeability. Gastroenterology 112: 100-108, 1997.
43. Wachtershauser A, Stein J. Rationale for the luminal provision of butyrate in intestinal diseases. Eur J Nutr 39: 164-171, 2000.
44. Walker GE, Wilson EM, Powell D, Oh Y. Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex. Endocrinology 142: 3817-3827, 2001.
45. + exchanger knockout model of congenital diarrhea. J Biol Chem 277: 49036-49046, 2002.
46. Xu H, Chen R, Ghishan FK. Subcloning, localization, and expression of the rat intestinal sodium-hydrogen exchanger isoform 8. Am J Physiol Gastrointest Liver Physiol 289: G36-G41, 2005.
47. + exchange. Annu Rev Physiol 67: 411-443, 2005.